000 | 01852 a2200493 4500 | ||
---|---|---|---|
005 | 20250516035537.0 | ||
264 | 0 | _c20110830 | |
008 | 201108s 0 0 eng d | ||
022 | _a0006-3002 | ||
024 | 7 |
_a10.1016/j.bbalip.2011.04.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEl-Mowafy, A M | |
245 | 0 | 0 |
_aEicosapentaenoic acid ablates valproate-induced liver oxidative stress and cellular derangement without altering its clearance rate: dynamic synergy and therapeutic utility. _h[electronic resource] |
260 |
_bBiochimica et biophysica acta _c |
||
300 |
_a460-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAlanine Transaminase _xblood |
650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticonvulsants _xadministration & dosage |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aEicosapentaenoic Acid _xadministration & dosage |
650 | 0 | 4 |
_aGlutathione _xmetabolism |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMetabolic Clearance Rate _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aPentylenetetrazole _xtoxicity |
650 | 0 | 4 |
_aPeroxidase _xmetabolism |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSeizures _xchemically induced |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
650 | 0 | 4 |
_aValproic Acid _xadministration & dosage |
650 | 0 | 4 |
_agamma-Glutamyltransferase _xblood |
700 | 1 | _aAbdel-Dayem, M A | |
700 | 1 | _aAbdel-Aziz, A | |
700 | 1 | _aEl-Azab, M F | |
700 | 1 | _aSaid, S A | |
773 | 0 |
_tBiochimica et biophysica acta _gvol. 1811 _gno. 7-8 _gp. 460-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbalip.2011.04.014 _zAvailable from publisher's website |
999 |
_c20833712 _d20833712 |